Molycorp (NYSE: MCP) Reports Third Quarter 2013 Financial Results

7 november 2013 HIGHLIGHTS: * Total volume amounted to 3,620 metric tons (mt), a 19% increase over the second quarter, at an average selling price (ASP) of $41.18 per kilogram.  Net revenues for the quarter were $149.1 million, up 9% from the second quarter of the year. * The Company reported a net loss of $0.43 per share for the quarter. The Company reported a net loss of $0.27 per share for the quarter on an adjusted non-GAAP basis. * In the Chemicals and Oxides segment, volume of its advanced materials and other products, including mixed oxides, increased 34% from the second quarter. Pricing also increased 4% from the second quarter to drive revenues to $58.0 million, nearly a 40% increase over the same period. * In the Magnetic Materials and Alloys segment, volume of Magnequench bonded Neo Powders(TM) and other alloys increased 20% from the second quarter. Pricing decreased 9% to drive revenues to $72.6 million, a 10% increase over the same period. Greenwood Village, CO (November 7, 2013, 4:01 p.m. Eastern) - Molycorp, Inc. (NYSE: MCP) ("Molycorp" or the "Company") ($MCP) today announced financial and operating results for the third quarter of 2013. THIRD QUARTER 2013 RESULTS The Company reported consolidated net revenues of $149.1 million, a 9% increase over the second quarter of 2013. The increase in revenues was primarily attributable to higher product volumes and slightly higher ASPs in the Chemicals and Oxides segment and higher product volumes for its Magnetic Materials and Alloys segment. During the third quarter, the Company sold 3,620 mt of product at an ASP of $41.18 per kilogram, and generated a gross loss of $17.8 million. This compares to volume sales of 3,039 mt at an ASP of $45.04 per kilogram and a gross loss of $18.5 million during the second quarter of 2013. Molycorp reported a loss attributable to common stockholders of $72.8 million, or $0.43 per share. Adjusted loss per share of $0.27 in the third quarter 2013 eliminates the effect of operational expansion items, out-of-ordinary business expenses, and certain other non-cash items. The Company reported negative cash flows from operating activities of $90.0 million during the first nine months of 2013, and had $173.9 million in cash and cash equivalents as of September 30, 2013. During the quarter the company reported negative operating cash flow of $16.0 million, a 54% improvement over the prior quarter of negative $34.7 million. During the three months ended September 30, 2013, Molycorp's capital expenditures were $69.9 million on a cash basis. For the remainder of 2013, the Company estimates that its capital expenditures will total approximately $60 million. CONFERENCE CALL TODAY AT 4:30 P.M. EASTERN DAYLIGHT TIME Molycorp will conduct a conference call today to discuss these results at 4:30 p.m. EDT, hosted by Mr. Karayannopoulos, President and Chief Executive Officer, Michael Doolan, Executive Vice President and Chief Financial Officer, and Geoff Bedford, Executive Vice President and Chief Operating Officer. Investors interested in participating in the live call from the U.S. should dial +1 (877) 474-9503 and reference passcode number 859736683. Those calling from outside the U.S. should dial +1 (857) 244-7556 and reference the same passcode as above. There will also be a simultaneous live audio webcast available on the Investor Relations section of the Company's website at www.molycorp.com/investors. The webcast will be archived on the website. A PowerPoint presentation that will be broadcast live via webcast during the conference call will be made available on the website immediately prior to the call. NON-GAAP ADJUSTED NET LOSS, EBITDA and ADJUSTED EBITDA Adjusted net loss is a non-GAAP measure that excludes certain non-cash items and other out-of-ordinary business expense and operational expansion items. EBITDA is also a non-GAAP measure that excludes interest, tax, depreciation and amortization. Adjusted EBITDA consists of EBITDA excluding certain non-cash items and other out-of-ordinary business expense and operational expansion items. The Company's management believes adjusting out these items, including but not limited to purchase accounting adjustments, stock-based compensation, out-of-ordinary expenses/income, asset impairment charges and other miscellaneous charges, is useful to investors because it provides an overall understanding of the Company's historical financial performance and future prospects. Management believes adjusted net loss, EBITDA and adjusted EBITDA are an indication of the Company's base-line performance. Exclusion of these items permits evaluation and comparison of results for the Company's core business operations, and it is on this basis that management internally assesses the Company's performance. # # # FOR MORE INFORMATION: Company Contacts: Jim Sims, +1 (303) 843-8062 Vice President Corporate Communications Jim.Sims@Molycorp.com Brian Blackman, +1 (303) 843-8067 Vice President Investor Relations Brian.Blackman@Molycorp.com ______________________________ FINANCIAL STATEMENTS AND SUPPLEMENTARY TABLES TABLE 1: BALANCE SHEETS MOLYCORP, INC. Consolidated Balance Sheets (In thousands, except share and per share amounts) September December   30, 2013   31, 2012 ------------------ ---------------- ASSETS Current assets: Cash and cash equivalents $ 173,914   $ 227,790 Trade accounts receivable, net   58,200     52,430 Inventory   183,441     287,376 Deferred charges   3,080     9,412 Deferred tax assets   8,478     9,789 Income tax receivable   20,296     25,087 Prepaid expenses and other current assets   25,660     21,794 ------------------ ---------------- Total current assets   473,069     633,678 ------------------ ---------------- Non-current assets: Deposits   25,997     26,769 Property, plant and equipment, net   1,779,084     1,544,304 Inventory   24,325     26,096 Intangible assets, net   419,471     450,938 Investments   58,749     64,036 Goodwill   239,742     239,742 Other non-current assets   6,839     6,972 ------------------ ---------------- Total non-current assets   2,554,207     2,358,857 ------------------ ---------------- Total assets $ 3,027,276   $ 2,992,535 ------------------ ---------------- LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Trade accounts payable $ 107,882   $ 241,994 Accrued expenses   61,445     59,013 Income tax payable   1,708     15,267 Debt and capital lease obligations   16,673     39,604 Other current liabilities   6,689     3,539 ------------------ ---------------- Total current liabilities   194,397     359,417 ------------------ ---------------- Non-current liabilities: Asset retirement obligation   14,084     18,586 Deferred tax liabilities   125,142     160,675 Debt and capital lease obligations   1,356,256     1,188,832 Derivative liability   6,819     7,816 Pension liabilities   3,431     3,292 Other non-current liabilities   2,052     2,659 ------------------ ---------------- Total non-current liabilities   1,507,784     1,381,860 ------------------ ---------------- Total liabilities $ 1,702,181   $ 1,741,277 ------------------ ---------------- MOLYCORP, INC. Consolidated Balance Sheets (Continued) (In thousands, except share and per share amounts) September December   30, 2013   31, 2012 ------------------ ---------------- Stockholders' equity: Common stock, $0.001 par value; 350,000,000 shares authorized at September 30, 2013   189     139 Preferred stock, $0.001 par value; 5,000,000 shares authorized at September 30, 2013   2     2 Additional paid-in capital   1,946,742     1,691,429 Accumulated other comprehensive loss    (7,848)      (9,433) Accumulated deficit    (646,163)      (466,091) ------------------ ---------------- Total Molycorp stockholders' equity    1,292,922      1,216,046 Noncontrolling interests   32,173      35,212 ------------------ ---------------- Total stockholders' equity    1,325,095      1,251,258 ------------------ ---------------- Total liabilities and stockholders' equity $  3,027,276   $ 2,992,535 ------------------ ---------------- TABLE 2: INCOME STATEMENTS MOLYCORP, INC. Consolidated Statements of Operations and Comprehensive Income (In thousands, except per share amounts)   Three Months Ended Nine Months Ended September September 30,   30, ----------------------------- ----------------------------   2013   2012   2013   2012 -------------- -------------- -------------- ------------- Revenues $  149,066   $  205,205   $  430,580   $  394,085 Costs of sales: Costs excluding depreciation and amortization    (150,444)    (183,227)    (421,699)    (336,654) Depreciation and amortization    (16,400)    (10,612)    (49,283)    (19,065) -------------- -------------- -------------- ------------- Gross (loss) profit    (17,778)      11,366      (40,402)      38,366 Operating expenses: Selling, general and administrative    (24,399)    (31,349)    (76,446)    (78,583) Corporate development    (69)    (1,073)    (256)    (19,379) Depreciation, amortization and accretion    (10,072)    (9,584)    (26,273)    (12,188) Research and development    (5,565)    (8,929)    (18,476)    (18,628) Impairment of goodwill and other long-lived assets    (1,118)    -    (1,495)    - -------------- -------------- -------------- ------------- Operating loss    (59,001)      (39,569)      (163,348)      (90,412) -------------- -------------- -------------- ------------- Other (expense) income: Other income (expense)    (657)    (57)    1,430    (37,615) Foreign exchange (loss) gain , net    (234)    1,910    1,044    724 Interest expense, net of capitalized interest    (16,289)    (5,269)    (42,807)    (14,989) -------------- -------------- -------------- -------------      (17,180)      (3,416)      (40,333)      (51,880) -------------- -------------- -------------- ------------- Loss before income taxes and equity earnings    (76,181)    (42,985)    (203,681)    (142,292) Income tax benefit    12,902      28,956      38,922      58,442 Equity in results of affiliates    (2,334)    (662)    (8,690)    (1,146) -------------- -------------- -------------- ------------- Loss from continuing operations    (65,613)    (14,691)    (173,449)    (84,996) Loss from discontinued operations, net of tax    (4,186)    (760)    (5,190)    (860) -------------- -------------- -------------- ------------- Net loss    (69,799)      (15,451)      (178,639)      (85,856) Net income attributable to noncontrolling interest    (130)    (3,440)    (1,433)    (4,120) -------------- -------------- -------------- ------------- Net loss attributable to $   $   $   $ Molycorp stockholders  (69,929)  (18,891)  (180,072)  (89,976) -------------- -------------- -------------- ------------- Net loss $  (69,799)   $  (15,451)   $  (178,639)   $  (85,856) Other comprehensive income: Foreign currency translation adjustments    4,217    526    1,585    (1,165) -------------- -------------- -------------- ------------- Comprehensive loss $  (65,582)   $  (14,925)   $  (177,054)   $  (87,021) -------------- -------------- -------------- ------------- Comprehensive loss attributable to: Molycorp stockholders    (65,452)    (11,485)    (175,621)    (82,901) Noncontrolling interest    (130)    (3,440)    (1,433)    (4,120) -------------- -------------- -------------- -------------   $  (65,582)   $  (14,925)   $  (177,054)   $  (87,021) -------------- -------------- -------------- -------------  Loss per share of common stock: Basic:    Continuing operations $  (0.41)   $  (0.18)   $  (1.12)   $  (0.97)    Discontinued operations    (0.02)      (0.01)      (0.03)      (0.01) ----------- ----------- ----------- ----------   $  (0.43)   $  (0.19)   $  (1.16)   $  (0.97) ----------- ----------- ----------- ---------- Diluted:    Continuing operations $  (0.41)   $  (0.18)   $  (1.12)   $  (0.97)    Discontinued operations    (0.02)      (0.01)      (0.03)      (0.01) ----------- ----------- ----------- ----------   $  (0.43)   $  (0.19)   $  (1.16)   $  (0.97) ----------- ----------- ----------- ----------  TABLE 3: STATEMENTS OF CASH FLOWS MOLYCORP, INC Consolidated Statements of Cash Flows (Unaudited) (In thousands)   Nine Months Ended September 30, ------------------------------   2013   2012 -------------- --------------- Cash flows from operating activities: Net loss $  (178,639)   $  (85,856) Adjustments to reconcile net loss to net cash from operating activities: Depreciation, amortization and accretion    75,870      31,426 Deferred income tax benefit    (36,399)      (35,179) Inventory write-downs    74,475      41,082 Release of inventory step-up value    5,650      26,428 Impairment of long-lived assets    4,949      - Stock-based compensation expense    2,399      3,179 Allowance for doubtful accounts    -      2,500 Foreign exchange loss    (145)      - Equity in results of affiliates    8,690      1,146 Other operating adjustments    (1,651)      167 Net change in operating assets and liabilities    (45,212)      (32,081) -------------- --------------- Net cash used in operating activities    (90,013)      (47,188) -------------- --------------- Cash flows from investing activities: Cash paid in connection with acquisition, net of cash acquired    -    (591,011) Investment in joint ventures    (3,423)      (28,130) Deposits    -      (516) Capital expenditures    (334,597)      (644,683) Other investing activities    (364)      4,953 -------------- --------------- Net cash used in investing activities    (338,384)      (1,259,387) -------------- --------------- Cash flows from financing activities: Capital contributions    -      390,225 Repayments of debt    (25,990)      (228,431) Net proceeds from sale of common stock    248,150      132,471 Net proceeds from sale of Senior Notes    -      635,373 Issuance of 5.50% Convertible Notes    165,600     - Issuance of 6.00% Convertible Notes    -      395,712 Payments of preferred dividends    (8,539)      (8,539) Proceeds from debt    -      9,456 Dividend paid to noncontrolling interests    (4,472)     - Other financing activities    (797)      (3,331) -------------- --------------- Net cash provided by financing activities    373,952      1,322,936 Effect of exchange rate changes on cash    569      809 -------------- --------------- Net change in cash and cash equivalents    (53,876)      17,170 Cash and cash equivalents at beginning of the period    227,790    418,855 -------------- --------------- Cash and cash equivalents at end of period $  173,914   $  436,025 -------------- --------------- TABLE 4: SEGMENT INFORMATION             Magnetic     Chemicals   Materials       Corporate       Total     and and and Molycorp, Three months ended Resources   Oxides   Alloys   Rare   other(a)   Eliminations(b)   Inc. September Metals 30, 2013 --------------- ------------ ----------- ----------- ---------- ------------ ----------------- ----------- Revenues:   (In thousands of dollars) External    4,655    50,791    72,626    20,994        -    149,066 Intersegment    8,858    7,174    -    -        (16,032)    - ------------ ----------- ----------- ---------- ----------------- ----------- Total revenues  13,513  57,965  72,626  20,994  (16,032)  149,066 ------------ ----------- ----------- ---------- ----------------- ----------- Depreciation, amortization and accretion  (10,853)  (5,960)  (7,458)  (2,144)  (57)  -  (26,472) Operating (loss) income  (55,526)  (1,399)  11,062  (3,055)  (10,806)  723  (59,001) (Loss) income before income taxes and equity earnings  (56,139)  (1,527)  39,291  (4,807)  (53,722)  723  (76,181) Total assets at September 30, 2013  1,880,127  567,207  621,127  100,794  1,329,485  (1,471,464)  3,027,276 Capital expenditures (c)  57,637  1,573  1,457  1,946  77  -  62,690             Magnetic     Chemicals   Materials       Corporate       Total     and and and Molycorp, Three months ended Resources   Oxides   Alloys   Rare   other(a)   Eliminations(b)   Inc. September Metals 30, 2012 --------------- ----------- ----------- ----------- ---------- ----------- ----------------- ---------- Revenues:   (In thousands of dollars) External    17,150    87,820    74,789    25,446        -    205,205 Intersegment    3,745    11,559    -    -        (15,304)    - ----------- ----------- ----------- ---------- ----------------- ---------- Total revenues  20,895  99,379  74,789  25,446  (15,304)  205,205 ----------- ----------- ----------- ---------- ----------------- ---------- Depreciation, amortization and accretion  (4,035)  (5,685)  (8,857)  (1,576)  (43)  -  (20,196) Operating (loss) income  (23,966)  2,149  1,419  (3,014)  (16,526)  369  (39,569) (Loss) income before income taxes and equity earnings  (25,506)  1,201  1,215  (3,052)  (17,212)  369  (42,985) Capital expenditures (c)  187,611  2,597  1,432  2,837  1,387  -  195,864 a. Corporate loss before income taxes and equity earnings includes business development costs, personnel and related costs, including stock-based compensation expense, accounting and legal fees, occupancy expense, information technology costs and interest expense. Total corporate assets is comprised primarily of cash and cash equivalents. b. The net elimination in operating results includes costs of sales eliminations of $16,755 and $15,673 for the three months ended September 30, 2013 and 2012, respectively. Costs of sales eliminations consist of intercompany gross profits as well as eliminations of lower of cost or market adjustments related to intercompany inventory. The total assets elimination is comprised primarily of intercompany investments and intercompany accounts receivable and profits in inventory. c. On an accrual basis excluding capitalized interest. TABLE 5: LOSS PER SHARE   Three Months Ended September 30, -------------------------------- (In thousands, except share and per share 2013   2012 amounts) ---------------- --------------- Net loss attributable to Molycorp $  (69,929)   $  (18,891) stockholders: Dividends on Convertible Preferred Stock    (2,846)      (2,846) ---------------- --------------- Loss attributable to common stockholders    (72,775)      (21,737) ---------------- ---------------    Continuing operations    (68,589)      (20,977)    Discontinued operations    (4,186)      (760) ---------------- ---------------   $  (72,775)   $  (21,737) ---------------- --------------- Weighted average common shares outstanding-  168,114,266    117,086,022 basic Basic loss per share:    Continuing operations $  (0.41)   $  (0.18)    Discontinued operations    (0.02)      (0.01) ---------------- ---------------   $  (0.43)   $  (0.19) ---------------- --------------- Diluted loss per share:    Continuing operations $  (0.41)   $  (0.18)    Discontinued operations    (0.02)      (0.01) ---------------- ---------------   $  (0.43)   $  (0.19) ---------------- --------------- TABLE 6: PRODUCT REVENUES, VOLUMES, ASP   Three Months Ended September 30, ------------------------------------ Revenues (in thousands) 2013   2012 ----------------- ---------------- Resources (1) $  13,513   $  20,895 Chemicals and Oxides (2)    57,965      99,379 Magnetic Materials and Alloys (3)    72,626      74,789 Rare Metals (4)    20,994      25,446 Intersegments eliminations    (16,032)      (15,304) ----------------- ---------------- Total Net Revenues $  149,066   $  205,205 ----------------- ----------------   Three Months Ended September 30, ----------------------------------- Volumes (in metric tons) 2013   2012 ---------------- ---------------- Resources    1,080      835 Chemicals and Oxides    1,696      1,933 Magnetic Materials and Alloys    1,783      1,527 Rare Metals    102      96 Intersegments eliminations    (1,041)      (720) ---------------- ----------------      3,620      3,671 ---------------- ----------------   Three Months Ended September 30, ----------------------------------- ASP per kilogram 2013   2012 --------------- ----------------- Resources $  12.51   $  25.02 Chemicals and Oxides $  34.18   $  51.41 Magnetic Materials and Alloys $  40.73   $  48.98 Rare Metals $  205.82   $  269.22 1. The Resources segment includes the Company's operations at its Molycorp Mountain Pass facility where it conducts rare earth minerals extraction to produce: purified unseparated light rare earth concentrates; separated rare earth oxides, or REO, including lanthanum, cerium and neodymium/praseodymium; heavy rare earth concentrate, which includes samarium, europium, gadolinium, or SEG, terbium, dysprosium, and others; and SorbX(TM), a line of proprietary rare earth-based water treatment products. 2. The Chemicals and Oxides division includes: production of REO at the Company's operations in Sillamäe, Estonia; heavy rare earth oxides other custom engineered materials from the Company's facilities in Jiangyin, Jiangsu Province, China; and production of REO, salts of rare earth elements, zirconium- based engineered materials and mixed rare earth/zirconium oxides from the Company's facilities in Zibo, Shandong Province, China. Rare earth and zirconium applications from products made in this segment include catalytic converters, computers, television display panels, optical lenses, mobile phones, electronic chips, and many others. 3. The Magnetic Materials and Alloys segment includes: the production of Neo Powders(TM) through the Company's wholly-owned manufacturing facilities in Tianjin, China, and Korat, Thailand, under the Molycorp Magnequench brand. This operating segment also includes manufacturing of neodymium and samarium magnet alloys, other specialty alloy products and rare earth metals at the Molycorp Metals and Alloys facility, located in Tolleson, Arizona. Neo Powders(TM) are used in micro motors, precision motors, sensors, and other applications requiring high levels of magnetic strength, flexibility, small size, and reduced weight. 4. The Rare Metals segment produces, reclaims, refines and markets high value niche metals and their compounds that include gallium, indium, rhenium, tantalum, and niobium. Operations in this segment include the following: Quapaw, Oklahoma; Blanding, Utah; Peterborough, Ontario; Sagard, Germany; Hyeongok Industrial Zone in South Korea; and Sillamäe, Estonia. Applications from products made in this segment include wireless technologies, light-emitting diode, flat panel display, turbine, solar, catalyst, steel additive, electronics applications, and others. In July 2013, the Company committed to a plan to discontinue operations at its Napanee, Ontario - Canada facility by the end of fiscal 2013 due to a declining demand for rhenium combined with unfavorable operating costs in this particular recycling sector. Therefore, the operating results of the Napanee facility were included in discontinued operations for the three and nine months ended September 30, 2013, and the prior period presentation of financial data for the Rare Metals segment has been revised for comparative purposes. TABLE 7: NON-GAAP ADJUSTED NET LOSS, EBITDA and ADJUSTED EBITDA RECONCILIATION (In thousands, except share and per share data) Adjusted Net Loss   Three Months Ended September 30, -------------------------------   2013   2012 ---------------- -------------- Net loss attributable to Molycorp stockholders $  (69,929)   $  (18,891) Certain non-cash and other items: Stock-based compensation    1,687      1,279 Inventory write-downs    20,264      14,976 Impact of purchase accounting on cost of  2,151    18,067 inventory sold Impairment of long-lived assets    3,454      - Out-of-ordinary items: Water removal    5,146      3,174 Molycorp Mountain Pass non-capitalizable costs    -      4,958 Business Expansion items: Due diligence and other transaction costs    -      1,001 Other business expansion expenses    -      1,743 Release of tax provision    -      (15,100) Income tax effect of above adjustments    (5,850)      (14,463) ---------------- -------------- Adjusted net (loss) income    (43,077)      (3,256) Dividends on Convertible Preferred Stock    (2,846)      (2,846) ---------------- -------------- Adjusted net (loss) income attributed to common $  (45,923)   $  (6,102) stockholders ---------------- -------------- Weighted average common shares outstanding    168,114,266     117,086,022 ---------------- -------------- Adjusted net (loss) earnings per share $  (0.27)   $  (0.05) ---------------- -------------- EBITDA and Adjusted EBITDA Three months ended September 30, 2013 ------------------------------------ Operating loss $  (59,001) Depreciation and amortization included in  16,400 costs of sales Depreciation, amortization and accretion    10,072 ------------------------------------ EBITDA    (32,529) ------------------------------------ Stock-based compensation    1,687 Inventory write-downs    20,264 Impact of purchase accounting on cost of  2,151 inventory sold Impairment of long-lived assets    3,454 Water removal    5,146 ------------------------------------ Adjusted EBITDA $  173 ------------------------------------ ABOUT MOLYCORP Molycorp is the only advanced material manufacturer in the world that both controls a world-class rare earth resource and can produce high-purity, custom engineered rare earth products to meet increasingly demanding customer specifications. A globally integrated manufacturer, the Company produces a wide variety of specialized products from 13 different rare earths (lights and heavies), five rare metals (gallium, indium, rhenium, tantalum and niobium), and the transition metals yttrium and zirconium. With 27 locations across 11 countries, Molycorp also produces rare earth magnetic materials through its Molycorp Magnequench subsidiary, including neodymium-iron-boron ("NdFeB") magnet powders, used to manufacture bonded NdFeB permanent rare earth magnets. Through its joint venture with Daido Steel and the Mitsubishi Corporation, Molycorp manufactures next-generation, sintered NdFeB permanent rare earth magnets. Through its Molycorp Advanced Water Technologies subsidiary, the Company markets and sells its proprietary, cerium-based advanced water purification technology called SorbX(TM) for use in municipal and industrial wastewater treatment, recreational water, and pool and spa water treatment markets. For more information please visit http://www.molycorp.com. SAFE HARBOR STATEMENT REGARDING FORWARD-LOOKING STATEMENTS This release contains forward-looking statements that represent Molycorp's beliefs, projections and predictions about future events or Molycorp's future performance. Forward-looking statements can be identified by terminology such as "may," "will," "would," "could," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other similar expressions or phrases. These forward- looking statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause Molycorp's actual results, performance or achievements or industry results to differ materially from any future results, performance or achievement described in or implied by such statements. Factors that may cause actual results to differ materially from expected results described in forward-looking statements include, but are not limited to:  the potential need to secure additional capital to implement Molycorp's business plans, and Molycorp's ability to successfully secure any such capital; Molycorp's ability to complete its planned capital projects, such as its modernization and expansion efforts, including the achievement of an initial annual production rate of 19,050 metric tons at the Mountain Pass rare earth mine and processing facility, which we refer to as the Molycorp Mountain Pass facility, and reach full planned production rates for REO and other planned downstream products, in each case within the projected time frame; the success of Molycorp's cost mitigation efforts in connection with the modernization and expansion efforts at the Molycorp Mountain Pass facility, which, if unsuccessful, might cause its costs to exceed budget; the final costs of Molycorp's planned capital projects, which may differ from estimated costs; Molycorp's ability to successfully integrate Neo Material Technologies, Inc. (now Molycorp Canada), with its operations; Molycorp's ability to achieve fully the strategic and financial objectives related to the acquisition of Molycorp Canada, including the acquisition's impact on Molycorp's financial condition and results of operations; unexpected costs or liabilities that may arise from the acquisition, ownership or operation of Molycorp Canada; risks and uncertainties associated with intangible assets, including any future goodwill impairment charges; market conditions, including prices and demand for Molycorp's products; Molycorp's ability to control its working capital needs; foreign exchange rate fluctuations; the development and commercialization of new products; unexpected actions of domestic and foreign governments; various events which could disrupt operations, including natural events and other risks; uncertainties associated with Molycorp's reserve estimates and non-reserve deposit information, including estimated mine life and annual production; uncertainties related to feasibility studies that provide estimates of expected or anticipated costs, expenditures and economic returns, REO prices, production costs and other expenses for operations, which are subject to fluctuation; uncertainties regarding global supply and demand for rare earths materials; uncertainties regarding the results of Molycorp's exploratory drilling programs; Molycorp's ability to enter into additional definitive agreements with its customers and its ability to maintain customer relationships; Molycorp's sintered neodymium-iron-boron rare earth magnet joint venture's ability to successfully manufacture magnets within its expected timeframe; Molycorp's ability to successfully integrate other acquired businesses; Molycorp's ability to maintain appropriate relations with unions and employees; Molycorp's ability to successfully implement its vertical integration strategy; environmental laws, regulations and permits affecting Molycorp's business, directly and indirectly, including, among others, those relating to mine reclamation and restoration, climate change, emissions to the air and water and human exposure to hazardous substances used, released or disposed of by Molycorp; and uncertainties associated with unanticipated geological conditions related to mining; and the outcome of the stockholder class action litigation, derivative litigation and the SEC investigation, including any actions taken by government agencies in connection therewith. For more information regarding these and other risks and uncertainties that Molycorp may face, see the section entitled "Risk Factors" of the Company's Annual Report on Form 10-K for the year ended December 31, 2012 and of the Company's Quarterly Reports on Form 10-Q. Any forward-looking statement contained in this release or the Annual Report on Form 10-K or the Quarterly Reports on Form 10-Q reflects Molycorp's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Molycorp's operations, operating results, growth strategy and liquidity. You should not place undue reliance on these forward-looking statements because such statements speak only as to the date when made. Molycorp assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future, except as otherwise required by applicable law. This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Molycorp, Inc. via Thomson Reuters ONE [HUG#1741623]